BodyGuardian Remote Monitoring System vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BodyGuardian Remote Monitoring System

by Boston Scientific Cardiac Diagnostics

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

Tool A, the BodyGuardian Remote Monitoring System, offers a non-invasive, wearable solution for detecting non-lethal cardiac arrhythmias, integrating multiple external monitoring technologies for flexible, shorter-term use. Conversely, Tool B, the LINQ II Insertable Cardiac Monitor, provides an implanted, long-term solution for continuous heart rhythm monitoring over several years, suitable for patients requiring extended surveillance. While both utilize AI for arrhythmia detection, their distinct form factors and monitoring durations cater to different clinical needs and patient preferences regarding invasiveness.

Choose BodyGuardian Remote Monitoring System if…

Choose BodyGuardian Remote Monitoring System if you require a flexible, non-invasive solution for short-to-medium term cardiac monitoring in ambulatory patients. This system is ideal for diagnosing non-lethal arrhythmias, offering the combined capabilities of Holter, event, and mobile cardiac telemetry in a comfortable, wearable device that integrates seamlessly into daily life.

View BodyGuardian Remote Monitoring System →

Choose LINQ II Insertable Cardiac Monitor if…

Choose LINQ II Insertable Cardiac Monitor if your patient requires discreet, long-term continuous heart rhythm monitoring, potentially for several years, to detect infrequent or cryptogenic arrhythmias. This device is particularly well-suited for situations where external monitoring has been inconclusive or when extended monitoring is necessary for risk stratification, offering superior patient compliance due to its insertable nature.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BodyGuardian Remote Monitoring System	LINQ II Insertable Cardiac Monitor
Deployment	Cloud-based platform with EMR integration.	Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BodyGuardian Remote Monitoring System

Tool A, the BodyGuardian, is a wearable device, which generally offers higher initial patient usability as it avoids a surgical procedure. Its comfortable and waterproof design further enhances patient adherence and ease of use in daily activities, making it more accessible for short-to-medium term monitoring.

Clinical Value

LINQ II Insertable Cardiac Monitor

Tool B, the LINQ II, provides superior clinical value due to its ability to offer continuous heart rhythm monitoring for up to 4.5 years, which is crucial for diagnosing infrequent arrhythmias. Its insertable nature eliminates patient compliance issues inherent with wearables, and it also boasts MRI compatibility and a pediatric indication, broadening its clinical utility.

Pricing & Value

Tie

Both tools lack public pricing transparency, with details typically negotiated directly with healthcare systems. Without specific cost information for either an insertable device and procedure (Tool B) or a wearable system (Tool A), it is impossible to definitively compare their pricing and overall value proposition.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool B, from Medtronic, explicitly targets a wide range of healthcare settings from solo practices to large health systems and has been adopted by over 1 million patients worldwide. This extensive customer base and stated target market demonstrate a strong track record and robust enterprise readiness.

Innovation

LINQ II Insertable Cardiac Monitor

Tool B's innovation lies in its long-term insertable cardiac monitoring capability (up to 4.5 years) combined with remote programming and advanced AccuRhythm AI algorithms for enhanced accuracy, including innovative PVC detection. This represents a more significant advancement in continuous, unobtrusive cardiac monitoring compared to Tool A's combination of existing wearable monitoring modalities.

Support & Docs

Tie

Both Medtronic (Tool B) and Boston Scientific Cardiac Diagnostics (Tool A) provide comprehensive support and documentation. This includes patient and clinician manuals, FAQs, and dedicated phone support lines, ensuring robust resources for users of both devices.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BodyGuardian Remote Monitoring System	LINQ II Insertable Cardiac Monitor
Device Type	Wearable body sensor	Insertable cardiac monitor
Company	Preventice Technologies (now Boston Scientific Cardiac Diagnostics)	Medtronic
Primary Use Case	Detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients	Long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias
AI Algorithms	BeatLogic deep learning AI for accurate rhythm analysis	AccuRhythmu2122 AI algorithms for enhanced accuracy
Monitoring Duration	Continuous cardiac monitoring (specific maximum duration not specified)	Up to 4.5 years of continuous monitoring
Pediatric Indication	Specialties include Pediatrics	Pediatric indication (ages 2+)